Literature DB >> 35373533

International consensus statement on allergy and rhinology: Olfaction.

Zara M Patel1, Eric H Holbrook2, Justin H Turner3, Nithin D Adappa4, Mark W Albers5, Aytug Altundag6, Simone Appenzeller7, Richard M Costanzo8, Ilona Croy9, Greg E Davis10, Puya Dehgani-Mobaraki11, Richard L Doty12, Valerie B Duffy13, Bradley J Goldstein14, David A Gudis15, Antje Haehner16, Thomas S Higgins17, Claire Hopkins18, Caroline Huart19, Thomas Hummel16, Kawinyarat Jitaroon20, Robert C Kern21, Ashoke R Khanwalkar1, Masayoshi Kobayashi22, Kenji Kondo23, Andrew P Lane24, Matt Lechner25, Donald A Leopold26, Joshua M Levy27, Michael J Marmura28, Lisha Mclelland29, Takaki Miwa30, Paul J Moberg31, Christian A Mueller32, Sagar U Nigwekar33, Erin K O'Brien34, Teodor G Paunescu33, Robert Pellegrino35, Carl Philpott36, Jayant M Pinto37, Evan R Reiter38, David R Roalf31, Nicholas R Rowan24, Rodney J Schlosser39, James Schwob40, Allen M Seiden41, Timothy L Smith42, Zachary M Soler39, Leigh Sowerby43, Bruce K Tan21, Andrew Thamboo44, Bozena Wrobel45, Carol H Yan46.   

Abstract

BACKGROUND: The literature regarding clinical olfaction, olfactory loss, and olfactory dysfunction has expanded rapidly over the past two decades, with an exponential rise in the past year. There is substantial variability in the quality of this literature and a need to consolidate and critically review the evidence. It is with that aim that we have gathered experts from around the world to produce this International Consensus on Allergy and Rhinology: Olfaction (ICAR:O).
METHODS: Using previously described methodology, specific topics were developed relating to olfaction. Each topic was assigned a literature review, evidence-based review, or evidence-based review with recommendations format as dictated by available evidence and scope within the ICAR:O document. Following iterative reviews of each topic, the ICAR:O document was integrated and reviewed by all authors for final consensus.
RESULTS: The ICAR:O document reviews nearly 100 separate topics within the realm of olfaction, including diagnosis, epidemiology, disease burden, diagnosis, testing, etiology, treatment, and associated pathologies.
CONCLUSION: This critical review of the existing clinical olfaction literature provides much needed insight and clarity into the evaluation, diagnosis, and treatment of patients with olfactory dysfunction, while also clearly delineating gaps in our knowledge and evidence base that we should investigate further.
© 2022 ARS-AAOA, LLC.

Entities:  

Keywords:  anosmia; evidence-based medicine; hyposmia; loss of smell; olfaction; olfactory dysfunction; olfactory loss; parosmia; phantosmia; systematic review

Mesh:

Year:  2022        PMID: 35373533     DOI: 10.1002/alr.22929

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  3 in total

1.  Analysis of Prevalence and Predictive Factors of Long-Lasting Olfactory and Gustatory Dysfunction in COVID-19 Patients.

Authors:  María A Callejón-Leblic; Daniel I Martín-Jiménez; Ramón Moreno-Luna; Jose M Palacios-Garcia; Marta Alvarez-Cendrero; Julissa A Vizcarra-Melgar; Carlos Fernandez-Velez; Isabel M Reyes-Tejero; Juan Maza-Solano; Jaime Gonzalez-Garcia; Beatriz Tena-García; María E Acosta-Mosquera; Alfonso Del Cuvillo; Serafín Sánchez-Gómez
Journal:  Life (Basel)       Date:  2022-08-17

2.  Drug-Associated Parosmia: New Perspectives from the WHO Safety Database.

Authors:  Diane Merino; Alexandre Olivier Gérard; Susanne Thümmler; Nouha Ben Othman; Delphine Viard; Fanny Rocher; Alexandre Destere; Elise Katheryne Van Obberghen; Milou-Daniel Drici
Journal:  J Clin Med       Date:  2022-08-09       Impact factor: 4.964

3.  Long-term quality-of-life impairment in patients with more than 1-year COVID-19-related olfactory dysfunction.

Authors:  Alfonso Luca Pendolino; Hui Qi Mandy Tan; David Choi; Giancarlo Ottaviano; Peter J Andrews
Journal:  Int Forum Allergy Rhinol       Date:  2022-08-09       Impact factor: 5.426

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.